Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

about

A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.

P2860

Q34417540-44606594-E017-47F2-A967-DBA18FFFBDC1

P2860

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

Item

http://www.wikidata.org/entity/Q43108358

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@en

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@nl

type

Item

label

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@en

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@nl

prefLabel

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@en

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@nl

P1476

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

@en

P2093

Elizabeth A Williamson

http://www.w3.org/2001/XMLSchema#string

Robert Hromas

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the human nucleotide excision repair gene ERCC1

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88

The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks

Mechanisms of Taxol resistance related to microtubules.

Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation

Synthetic lethality: exploiting the addiction of cancer to DNA repair.

Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents.

ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.

P304

926-927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/JNCI/DJT148

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237839561

http://www.w3.org/2001/XMLSchema#string

P698

23766531

http://www.w3.org/2001/XMLSchema#string

P932

3699441

http://www.w3.org/2001/XMLSchema#string

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

about

P2860

P2860

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932